Total Value
$3917.83B
Holdings Count
30
Period of Report
Dec 31, 2025
Report Type
HR
| Issuer | CUSIP | Value | Shares |
|---|---|---|---|
| NUVALENT INC | 670703107 | $530.05B | 5,269,433 |
| REVOLUTION MEDICINES INC | 76155X100 | $529.23B | 6,644,403 |
| ARCELLX INC | 03940C100 | $373.21B | 5,724,016 |
| GENMAB A/S | 372303206 | $216.83B | 7,039,834 |
| TARSUS PHARMACEUTICALS INC | 87650L103 | $209.79B | 2,562,154 |
| ABIVAX SA | 00370M103 | $191.15B | 1,417,473 |
| OLEMA PHARMACEUTICALS INC | 68062P106 | $188.60B | 7,544,172 |
| VAXCYTE INC | 92243G108 | $187.70B | 4,068,020 |
| SPDR SERIES TRUST | 78464A870 | $182.90B | 1,500,000 |
| CIDARA THERAPEUTICS INC | 171757206 | $167.78B | 759,565 |
| EDGEWISE THERAPEUTICS INC | 28036F105 | $162.32B | 6,541,210 |
| SCHOLAR ROCK HLDG CORP | 80706P103 | $134.89B | 3,062,157 |
| UROGEN PHARMA LTD | M96088105 | $104.77B | 4,473,648 |
| CRINETICS PHARMACEUTICALS IN | 22663K107 | $102.91B | 2,210,774 |
| APOGEE THERAPEUTICS INC | 03770N101 | $84.78B | 1,123,243 |
| EYEPOINT INC | 30233G209 | $67.44B | 3,691,475 |
| ERASCA INC | 29479A108 | $52.67B | 14,159,095 |
| BRIDGEBIO PHARMA INC | 10806X102 | $52.34B | 684,277 |
| ORUKA THERAPEUTICS INC | 687604108 | $51.84B | 1,710,316 |
| SPYRE THERAPEUTICS INC | 00773J202 | $48.07B | 1,467,266 |
| LEXEO THERAPEUTICS INC | 52886X107 | $47.30B | 4,763,198 |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | $44.91B | 1,443,102 |
| OCULAR THERAPEUTIX INC | 67576A100 | $35.63B | 2,935,284 |
| TERNS PHARMACEUTICALS INC | 880881107 | $32.74B | 810,286 |
| BRIDGEBIO ONCOLOGY THERAPEUT | 107924102 | $28.32B | 2,261,749 |
| VOR BIOPHARMA INC | 929033207 | $22.89B | 1,750,000 |
| ASSEMBLY BIOSCIENCES INC | 045396207 | $22.63B | 665,251 |
| ORIC PHARMACEUTICALS INC | 68622P109 | $19.64B | 2,401,217 |
| INVENTIVA SA | 46124U107 | $18.60B | 4,000,000 |
| KALARIS THERAPEUTICS INC | 482929106 | $5.91B | 700,000 |